ABVX Abivax SA - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 23, 2026
$92.88
· of 52w range
· above low
· to high
$69.8152w low
$148.8352w high
P/E
-27.9
EPS
$-4.83
your badges
52W Range
$70–$149
Analyst Rating
STRONG BUY
Price Target
$164
P/E
-27.9
ROE
-135.6%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ABVX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$92.88
P/E
-27.9
EPS
$-4.83
ROE
-135.6%
52W Range
$70–$149
ABVX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-4.832021-12-31 → 2025-12-31
Free Cash Flow$-161M2023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ABVX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -27.95Y avg ≈-11.2 | ≈-11.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ABVX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -85.1%5Y avg ≈-74.9% | ≈-74.9% | · | · | |
| ROE | -135.6%5Y avg ≈-143.3% | ≈-143.3% | · | · | |
| ROIC | -55.0%5Y avg ≈-182.1% | ≈-182.1% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ABVX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 8.75Y avg ≈4.9 | ≈4.9 | · | · | |
| Quick Ratio | 0.65Y avg ≈1.5 | ≈1.5 | · | · | |
| Interest Coverage | -2.25Y avg ≈-5.7 | ≈-5.7 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-27.2%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-2.09 | $-1.83 | -14.5% | |
| Dec. 31, 2025 | $-3.24 | $-1.52 | -112.5% | |
| June 30, 2025 | $-1.59 | $-1.58 | -0.57% | |
| Dec. 31, 2024 | $-1.50 | $-1.37 | -9.7% | |
| June 30, 2024 | $-1.29 | $-1.39 | 7.0% | |
| Dec. 31, 2022 | $-2.39 | $-1.80 | -33.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $178M | $147M | $103M | $48M | |
| SG&A Expense | $68M | $33M | $22M | $7M | |
| Operating Income | $-246M | $-173M | $-127M | $-65M | |
| Interest Expense | $112M | $17M | $28M | $7M | |
| Interest Income | $28M | $14M | $8M | $11M | |
| Pretax Income | $-330M | $-176M | $-148M | $-61M | |
| Income Tax | $6M | $0 | $0 | $0 | |
| Net Income | $-336M | $-176M | $-148M | $-61M | |
| EPS (Basic) | $-4.83 | $-2.80 | $-3.43 | $-3.18 | |
| EPS (Diluted) | $-4.83 | $-2.80 | $-3.43 | $-3.18 | |
| Shares (Basic) | 69,527,315 | 63,046,350 | 43,066,012 | 19,092,442 | |
| Shares (Diluted) | 69,527,315 | 63,046,350 | 43,066,012 | 19,092,442 | |
| EBITDA | $-246M | $-173M | $-127M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $57M | $234M | $27M | |
| Current Assets | $551M | $171M | $286M | $36M | |
| Goodwill | $18M | $18M | $18M | $18M | |
| Intangibles | $7M | $7M | $7M | $7M | |
| Total Assets | $584M | $205M | $327M | $76M | |
| Accounts Payable | $38M | $44M | $47M | $15M | |
| Current Liabilities | $63M | $94M | $91M | $51M | |
| Stockholders' Equity | $455M | $41M | $196M | $7M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-161M | $-154M | $-97M | $-54M | |
| CapEx | $142.0K | $640.0K | $265.0K | $288.0K | |
| Investing Cash Flow | $-8M | $16M | $-8M | $-12M | |
| Financing Cash Flow | $547M | $28M | $335M | $32M | |
| Free Cash Flow | $-161M | $-155M | $-97M | · | |
| Levered FCF | $-275M | $-172M | $-125M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -85.1% | -66.2% | -73.4% | · | |
| ROE | -135.6% | -149.0% | -145.4% | · | |
| ROIC | -55.0% | -426.2% | -65.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 8.7 | 1.8 | 4.1 | · | |
| Quick Ratio | 0.6 | 0.6 | 3.3 | · | |
| Interest Coverage | -2.2 | -10.2 | -4.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash Flow / Share | $-2.32 | $-2.44 | $-2.26 | · | |
| EPS (TTM) | $-4.83 | $-2.80 | $-3.43 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-336M | $-176M | $-148M | · | |
| P/E | -27.9 | -2.6 | -3.1 | · | |
| Earnings Yield | -3.6% | -38.2% | -32.1% | · |
No quarterly filings for ABVX
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-336M | $-176M | $-148M | $-61M | $-42M |
| Diluted EPS | $-4.83 | $-2.80 | $-3.43 | $-3.18 | $-2.75 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 8.7 | 1.8 | 4.1 | · | · |
| Quick Ratio | 0.6 | 0.6 | 3.3 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-161M | $-155M | $-97M | · | · |
Institutional owners (13F) 369 filers · $8.5B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
369
Value held
$8.5B
New positions
127
Exited positions
37
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 127 (+57 vs prior Q) | 37 (-7 vs prior Q) | 115 (-4 vs prior Q) | 105 (+29 vs prior Q) | +11.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $800,603,959 | 6,007,834 | 9.45% | Shares |
| Helikon Investments Ltd | $371,413,077 | 2,787,131 | 4.38% | Shares |
| Darwin Global Management, Ltd. | $348,215,205 | 3,621,583 | 4.11% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $327,659,688 | 2,458,800 | 3.87% | Call option |
| Vestal Point Capital, LP | $313,086,774 | 2,349,443 | 3.69% | Shares |
| UBS Group AG | $245,853,773 | 1,844,918 | 2.90% | Shares |
| ADAR1 Capital Management, LLC | $240,494,722 | 1,804,703 | 2.84% | Shares |
| CITADEL ADVISORS LLC | $213,855,648 | 1,604,800 | 2.52% | Call option |
| Caligan Partners LP | $207,608,952 | 1,557,924 | 2.45% | Shares |
| CITADEL ADVISORS LLC | $191,674,788 | 1,438,352 | 2.26% | Shares |
| MORGAN STANLEY | $190,852,973 | 1,432,185 | 2.25% | Shares |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $174,547,280 | 1,309,825 | 2.06% | Shares |
| CITADEL ADVISORS LLC | $159,991,956 | 1,200,600 | 1.89% | Put option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151,276,752 | 1,135,200 | 1.78% | Put option |
| RA CAPITAL MANAGEMENT, L.P. | $150,924,546 | 1,132,557 | 1.78% | Shares |
| NORGES BANK | $146,586,000 | 1,100,000 | 1.73% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140,442,181 | 1,053,896 | 1.66% | Shares |
| Logos Global Management LP | $136,458,240 | 1,024,000 | 1.61% | Shares |
| Octagon Capital Advisors LP | $132,327,180 | 993,000 | 1.56% | Shares |
| BANK OF AMERICA CORP /DE/ | $129,453,961 | 971,439 | 1.53% | Shares |
| Eversept Partners, LP | $121,783,649 | 913,880 | 1.44% | Shares |
| GOLDMAN SACHS GROUP INC | $105,636,801 | 792,712 | 1.25% | Shares |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $101,988,142 | 765,332 | 1.20% | Shares |
| JANUS HENDERSON GROUP PLC | $98,007,010 | 878,829 | 1.16% | Shares |
| Cormorant Asset Management, LP | $89,950,500 | 675,000 | 1.06% | Shares |
| Boxer Capital Management, LLC | $80,622,300 | 605,000 | 0.95% | Shares |
| Balyasny Asset Management L.P. | $80,467,718 | 603,840 | 0.95% | Shares |
| Siren, L.L.C. | $76,757,760 | 576,000 | 0.91% | Shares |
| BlackRock, Inc. | $76,499,369 | 574,061 | 0.90% | Shares |
| LMR Partners LLP | $75,531,768 | 566,800 | 0.89% | Call option |
| BOOTHBAY FUND MANAGEMENT, LLC | $75,074,286 | 563,367 | 0.89% | Shares |
| ORBIMED ADVISORS LLC | $72,829,522 | 546,522 | 0.86% | Shares |
| Aberdeen Group plc | $69,565,052 | 522,025 | 0.82% | Shares |
| Saturn V Capital Management LP | $69,143,950 | 518,865 | 0.82% | Shares |
| Artia Global Partners LP | $68,821,727 | 516,447 | 0.81% | Shares |
| Ensign Peak Advisors, Inc | $67,225,805 | 504,471 | 0.79% | Shares |
| Pictet Asset Management Holding SA | $65,572,982 | 492,068 | 0.77% | Shares |
| First Turn Management, LLC | $65,282,608 | 489,889 | 0.77% | Shares |
| Holocene Advisors, LP | $55,790,232 | 418,657 | 0.66% | Shares |
| Vivo Capital, LLC | $55,289,441 | 414,899 | 0.65% | Shares |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $54,636,600 | 410,000 | 0.64% | Shares |
| GREAT POINT PARTNERS LLC | $53,304,000 | 400,000 | 0.63% | Call option |
| EVENTIDE ASSET MANAGEMENT, LLC | $52,625,476 | 394,957 | 0.62% | Shares |
| ExodusPoint Capital Management, LP | $49,439,460 | 371,000 | 0.58% | Call option |
| DIADEMA PARTNERS LP | $46,534,392 | 349,200 | 0.55% | Call option |
| Ikarian Capital, LLC | $45,454,986 | 341,100 | 0.54% | Call option |
| MPM BIOIMPACT LLC | $44,821,601 | 336,347 | 0.53% | Shares |
| Affinity Asset Advisors, LLC | $43,975,800 | 330,000 | 0.52% | Shares |
| Ikarian Capital, LLC | $43,352,978 | 328,635 | 0.51% | Shares |
| Melqart Asset Management (UK) Ltd | $40,944,135 | 307,250 | 0.48% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Sofinnova Crossover I SLP, Sofinnova Partners SAS, Antoine Papiernik, Cedric Moreau, Kinam Hong, Joseph Anderson, Jacques Theurillat ×6 filings | July 6, 2026 | 4.30% | Amendment | Passive investment | SEC |
| Sofinnova Crossover I SLP (“SC”), Sofinnova Partners SAS (“SP SAS”), Antoine Papiernik (“Papiernik”), Cédric Moreau (“Moreau”), Kinam Hong (“Hong”), Joseph Anderson (“Anderson”), Jacques Theurillat (“Theurillat”) | Oct. 30, 2023 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 25 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 2.16% | 7,139 NS | July 31, 2026 | N-PORT |
| GURU · Global X Funds | 1.20% | 5,876 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.56% | 494,234 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.37% | 4,038 SH | Oct. 1, 2026 | Daily |
| EWQ · iShares, Inc. | 0.36% | 10,750 SH | Sept. 11, 2026 | Daily |
| ISCF · iShares Trust | 0.17% | 10,082 SH | Sept. 11, 2026 | Daily |
| ESIM · Strategy Shares | 0.13% | 182 NS | July 31, 2026 | N-PORT |
| EZU · iShares, Inc. | 0.10% | 83,061 SH | Sept. 11, 2026 | Daily |
| EFG · iShares Trust | 0.07% | 101,145 SH | Sept. 10, 2026 | Daily |
| DMXF · iShares Trust | 0.07% | 5,673 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.06% | 171,733 SH | Aug. 19, 2026 | Daily |
| IEUR · iShares Trust | 0.05% | 37,943 SH | Sept. 11, 2026 | Daily |
| IMTM · iShares Trust | 0.05% | 17,217 SH | Sept. 11, 2026 | Daily |
| EFA · iShares Trust | 0.03% | 233,209 SH | Sept. 11, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.03% | 680,945 SH | Aug. 19, 2026 | Daily |
| IEFA · iShares Trust | 0.03% | 485,263 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.02% | 68,440 SH | Sept. 10, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.02% | 1,051,957 SH | Aug. 19, 2026 | Daily |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 167,619 SH | Aug. 19, 2026 | Daily |
| ACWX · iShares Trust | 0.02% | 21,306 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.02% | 91,420 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 59,524 SH | Aug. 19, 2026 | Daily |
| TOK · iShares Trust | 0.01% | 151 SH | Sept. 9, 2026 | Daily |
| ACWI · iShares Trust | 0.01% | 19,903 SH | Sept. 11, 2026 | Daily |
| URTH · iShares, Inc. | 0.01% | 4,473 SH | Sept. 9, 2026 | Daily |
ABVX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$164.00
+76.6%
6 42.9%
Strong Buy
6 42.9%
Buy
2 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
12 analysts · 2026-09-30Mean target $164.00 +76.6%
← Below all targets
Current price $92.88
Low$142.00
Mean$164.00
High$181.00
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 23, 2026